I agree that this site is using cookies. You can find further informations here.
X
Popat, Rakesh
216  results:
Search for persons X
?
1

Clinical Management of Patients With Relapsed/Refractory Mu..:

Chari, Ajai ; Krishnan, Amrita ; Rasche, Leo...
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

The impact of continuous lenalidomide maintenance treatment..:

Buck, Caroline ; Brenes Castillo, Francisco ; Bettio, Elena...
Supportive Care in Cancer.  32 (2024)  7 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
3

Teclistamab Improves Patient-Reported Symptoms and Health-R..:

Martin, Thomas G. ; Moreau, Philippe ; Usmani, Saad Z....
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  3 - p. 194-202 , 2024
Link: https://doi.org/10.1016/..
 
?
4

The GLAMM1 Study - Global Access to Myeloma Medications: Po..:

Atallah, Rawan ; Shatnawi, Yara ; Mammadzadeh, Aytaj...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S373-S374 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Impact of timing of stem cell return following high dose me..:

Nesr, George ; Shah, Raakhee ; Kyriakou, Charalampia...
Leukemia & Lymphoma.  64 (2023)  8 - p. 1465-1471 , 2023
Link: https://doi.org/10.1080/..
 
?
6

P-322 Real world outcomes of belantamab mafodotin from the ..:

Watson, Edmund ; Djebbari, Faouzi ; Panitsas, Fotios...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S215-S216 , 2023
Link: https://doi.org/10.1016/..
 
?
7

POSTER: MM-163 Long-Term Follow-Up From MajesTEC-1 of Tecli..:

van de Donk, Niels ; Moreau, Philippe ; Garfall, Alfred...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S224 , 2023
Link: https://doi.org/10.1016/..
 
?
8

MM-163 Long-Term Follow-Up From MajesTEC-1 of Teclistamab, ..:

van de Donk, Niels ; Moreau, Philippe ; Garfall, Alfred...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S477-S478 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Plain language summary of the MajesTEC-1 study of teclistam..:

Moreau, Philippe ; van de Donk, Niels WCJ ; Nahi, Hareth...
Future Oncology.  19 (2023)  12 - p. 811-818 , 2023
Link: https://doi.org/10.2217/..
 
?
10

P-006 SBCMA has utility for early response monitoring in th..:

Dekhtiarenko, Iryna ; Attig, Jan ; Helms, Hans-Joachin...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S35-S36 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Infections following bispecific antibodies in myeloma: a sy..:

Reynolds, Gemma ; Cliff, Edward R. Scheffer ; Mohyuddin, Ghulam Rehman...
Blood Advances.  7 (2023)  19 - p. 5898-5903 , 2023
Link: https://doi.org/10.1182/..
 
?
12

POSTER: MM-360 Mezigdomide (MEZI) Plus Dexamethasone (DEX) ..:

Orlowski, Robert Z. ; Bahlis, Nizar J. ; Quach, Hang...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S226 , 2023
Link: https://doi.org/10.1016/..
 
?
13

P1518: INFECTIONS FOLLOWING BISPECIFIC ANTIBODIES IN MYELOM..:

Reynolds, Gemma ; Cliff, Edward R Scheffer ; Mohyuddin, Ghulam Rehman...
HemaSphere.  7 (2023)  S3 - p. e79367a6 , 2023
Link: https://doi.org/10.1097/..
 
?
14

MM-360 Mezigdomide (MEZI) Plus Dexamethasone (DEX) in Relap..:

Orlowski, Robert Z. ; Bahlis, Nizar J. ; Quach, Hang...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S492-S493 , 2023
Link: https://doi.org/10.1016/..
 
?
15

P865: TECLISTAMAB IN COMBINATION WITH LENALIDOMIDE IN PREVI..:

Tan, Carlyn ; Searle, Emma ; Anguille, Sébastien...
HemaSphere.  7 (2023)  S3 - p. e162590e , 2023
Link: https://doi.org/10.1097/..
 
1-15